<code id='E35A5B2C43'></code><style id='E35A5B2C43'></style>
    • <acronym id='E35A5B2C43'></acronym>
      <center id='E35A5B2C43'><center id='E35A5B2C43'><tfoot id='E35A5B2C43'></tfoot></center><abbr id='E35A5B2C43'><dir id='E35A5B2C43'><tfoot id='E35A5B2C43'></tfoot><noframes id='E35A5B2C43'>

    • <optgroup id='E35A5B2C43'><strike id='E35A5B2C43'><sup id='E35A5B2C43'></sup></strike><code id='E35A5B2C43'></code></optgroup>
        1. <b id='E35A5B2C43'><label id='E35A5B2C43'><select id='E35A5B2C43'><dt id='E35A5B2C43'><span id='E35A5B2C43'></span></dt></select></label></b><u id='E35A5B2C43'></u>
          <i id='E35A5B2C43'><strike id='E35A5B2C43'><tt id='E35A5B2C43'><pre id='E35A5B2C43'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:256
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          What to expect at HLTH 2023, the health care industry conference
          What to expect at HLTH 2023, the health care industry conference

          AdobeSTAT’sMohanaRavindranathandAnnalisaMerelliwillbeatHLTHinLasVegasandwillbewritingadailyemaildisp

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          VC firm General Catalyst wants to buy a health system

          AdobeVenturefirms,convincedthey’rejumpstartingtheworld’smosthelpfultechproducts,havestruggledmightil